Mitiglinide Calcium Hydrate

Cysolvia® is one of brands under Miedykol® a high-end and certified active pharmaceutical ingredients (APIs) and pharmaceutical intermediates manufacturer in China, mainly providing various APIs products and customized production (CMO/CDMO). We produce the mitiglinide calcium hydrate product which was developed earlist by the Japanese company Kissei and approved by there Ministry of Health, Labour and Welfare (こうせいろうどうしょう), used to treat type 2 diabetes. Its action mechanism is binding to sulfonylurea receptors on pancreatic beta cells, which is a key step in its glucose-lowering effect. It plays an effective role in controlling blood sugar levels in diabetic patients, especially in controlling postprandial blood sugar peaks. At Miedykol, we produce the innovative and market much-needed active ingredient products for special disease drugs managing arrhythmia, convulsion, postmenopausal osteoporosis, etc.. We also support your healthcare project and clinical therapies with the tailored production and integrative preparation solutions. Reach out to us for further information.